SAMHD1 expression contributes to doxorubicin resistance and predicts survival outcomes in diffuse large B-cell lymphoma patients.
Daddacha W, Monroe D, Schlafstein AJ, Withers AE, Thompson EB, Danelia D, Luong NC, Sesay F, Rath SK, Usoro ER, Essien ME, Jung AT, Jiang JG, Hu J, Mahboubi B, Williams A, Steinbeck JE, Yang X, Buchwald ZS, Dynan WS, Switchenko JM, Kim B, Khan MK, Jaye DL, Yu DS.
Daddacha W, et al. Among authors: jaye dl.
NAR Cancer. 2024 Feb 24;6(1):zcae007. doi: 10.1093/narcan/zcae007. eCollection 2024 Mar.
NAR Cancer. 2024.
PMID: 38406263
Free PMC article.